[1]
M. Boccadoro, “Retrospective study of thalidomide plus dexamethasone versus conventional chemotherapy in the relapsed multiple myeloma patient and the study of melphalan and prednisone versus melphalan, prednisone, and thalidomide”, Hematol Meeting Rep, vol. 1, no. 11, Jun. 2009.